Search research articles
Contact Us
Filters
Showing results (891-900 of 933) with videos related to
Page
of 94
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche
Laura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis
Peter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
European Urology
|
July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>†</sup>
Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany
Markus Krebs, Florian Haller, Silvia Spörl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 24, 2021
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients
Talia L Fuchs, Fiona Maclean, John Turchini, et al.
The American Journal of Surgical Pathology
|
July 16, 2014
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients
Anthony J Gill, Ondrej Hes, Thomas Papathomas, et al.
Urologic Oncology
|
December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 22, 2014
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
Mahul B Amin, Steven C Smith, Victor E Reuter, et al.
Cancer Cell
|
June 21, 2016
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, et al.
Page
of 94
Search research articles
Search
Showing results (891-900 of 933) with videos related to
Sort By:
Page
of 94
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche
Laura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2021
Mutations in <i>BRCA1/2</i> and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis
Peter A Fasching, Siddhartha Yadav, Chunling Hu, et al.
European Urology
|
July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>†</sup>
Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2024
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany
Markus Krebs, Florian Haller, Silvia Spörl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 24, 2021
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients
Talia L Fuchs, Fiona Maclean, John Turchini, et al.
The American Journal of Surgical Pathology
|
July 16, 2014
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients
Anthony J Gill, Ondrej Hes, Thomas Papathomas, et al.
Urologic Oncology
|
December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Laura S Mertens, Francesco Claps, Roman Mayr, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 22, 2014
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
Mahul B Amin, Steven C Smith, Victor E Reuter, et al.
Cancer Cell
|
June 21, 2016
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, et al.
Page
of 94